| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918899 | Radiotherapy and Oncology | 2013 | 5 Pages |
Abstract
A rapid decline in PSA in the first year following EBRT is positively associated with PCSM. This may be a useful early indicator of the need for additional therapies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Zumin Shi, Carole B. Pinnock, Stephen Kinsey-Trotman, Martin Borg, Kim L. Moretti, Scott Walsh, Tina Kopsaftis,